• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

September 16, 2013

Antibiotics Recommended for All Toddlers with Ear Infections

Author(s):

Aimee Simone, Assistant Editor

A team of researchers has recommended that all cases of acute otitis media in children aged 6 months to 2 years be treated with antibiotics, disagreeing with guidelines from the American Academy of Pediatrics.

A team of researchers has recommended that all cases of acute otitis media in children aged 6 months to 2 years be treated with antibiotics, disagreeing with guidelines from the American Academy of Pediatrics.

In a research letter published online on September 2, 2013, in JAMA Pediatrics, researchers recommend that all children aged 6 months to 2 years diagnosed with acute otitis media be treated with antibiotics, despite recent guidelines from the American Academy of Pediatrics (AAP) that recommend otherwise.

Guidelines released by the AAP in March 2013 recommend that children aged 6 months to 2 years diagnosed with acute otitis media without severe signs or symptoms and those with a unilateral infection be observed without initial antimicrobial treatment. For children with bilateral and severe infections, the AAP recommends treatment with antibiotics. These recommendations were based on the results of clinical trials indicating that antibiotics provided little benefit for children with one-sided and mild ear infections.

However, the authors of the research letter argue that some children enrolled in the trials used to formulate the AAP guidelines may not have actually had otitis media, given that the criteria used to diagnose their participants were less strict than those specified in the AAP guidelines. To evaluate the guidelines, the researchers, based at the University of Pittsburgh School of Medicine and Turku University Hospital in Finland, analyzed data from 2 previously published studies with strict requirements for diagnosing infections.

These blind trials, conducted in Pittsburgh, Pennsylvania, and Turku, Finland, randomly assigned young children diagnosed with acute otitis media to receive either amoxicillin—clavulanate potassium or placebo. In the Pittsburgh study, treatment failure was defined as lack of substantial improvement in symptoms or otoscopic signs 4 to 5 days after initiation or incomplete resolution of symptoms after 10 to 12 days. Treatment failure in the Turku trial was defined as lack of any improvement 3 days after beginning treatment, lack of improvement in otoscopic signs after 8 days, or worsening symptoms, tympanic membrane perforation, or medication discontinuation at any time. The results of both trials were combined for analysis.

Overall, the researchers found that treatment failure rates were significantly higher in the placebo group than in the antibiotic group and were similar among children with severe and non-severe infections and children with unilateral and bilateral infections. Antibiotic treatment failed in 14% of unilateral, non-severe cases, and in 25% of bilateral, severe cases. Placebo failed in 40% of unilateral, non-severe infections, and in 59% of bilateral, severe infections.

The authors conclude that their findings support a “uniform approach to antimicrobial treatment in children younger than 2 years with stringently diagnosed [acute otitis media].” They suggest that the AAP recommendations be changed to recommend antibiotics for children with unilateral and mild acute otitis media.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Related Content
Advertisement
raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
June 12th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Gardasil box next to syringes | Image Credit: © Unshu - stock.adobe.com
June 12th 2025

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pharmacy students -- Image credit: DusanJelicic | stock.adobe.com
June 12th 2025

Addressing Pharmacy Deserts and Expanding the Pharmaceutical Workforce

Gillian McGovern, Associate Editor
Hepatitis C virus model, 3D illustration. A virus consists of a protein coat, capsid, surrounding RNA and outer lipoprotein envelope with two types of glycoprotein spikes, E1 and E - Image credit: Dr_Microbe | stock.adobe.com
June 11th 2025

Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
June 12th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Gardasil box next to syringes | Image Credit: © Unshu - stock.adobe.com
June 12th 2025

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pharmacy students -- Image credit: DusanJelicic | stock.adobe.com
June 12th 2025

Addressing Pharmacy Deserts and Expanding the Pharmaceutical Workforce

Gillian McGovern, Associate Editor
Hepatitis C virus model, 3D illustration. A virus consists of a protein coat, capsid, surrounding RNA and outer lipoprotein envelope with two types of glycoprotein spikes, E1 and E - Image credit: Dr_Microbe | stock.adobe.com
June 11th 2025

Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.